Dysphagia in inflammatory myopathy: Clinical characteristics, treatment strategies, and outcome in 62 patients

Mayo Clinic Proceedings

Volumn 82, Issue 4, 2007, Pages 441-447

  Oh, Terry H ^a   Brumfield, Kathlyn A ^a   Hoskin, Tanya L ^a   Stolp, Kathryn A ^a   Murray, Joseph A ^a   Basford, Jeffrey R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AGED; CLINICAL FEATURE; CRICOPHARYNGEUS MUSCLE; DERMATOMYOSITIS; DISEASE ASSOCIATION; DYSPHAGIA; FEMALE; FLUOROSCOPY; HUMAN; INCIDENCE; INCLUSION BODY MYOSITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOSITIS; MYOTOMY; OROPHARYNX; OUTCOME ASSESSMENT; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; RETROSPECTIVE STUDY; REVIEW;

EID: 34047204142     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.4.441     Document Type: Article

References (30)

1. Dalakas M. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991;325:1487-1498.
2. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977;56:255-286.
3. Uthman I, Vázquez-Abad D, Senécal JL. Distinctive features of idiopathic inflammatory myopathies in French Canadians. Semin Arthritis Rheum. 1996;26:447-458.
4. Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol. 1996;14:263-274.
5. Benbassat J, Gelfel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis: a computer-assisted analysis on ninety-two cases. Arthritis Rheum. 1985;28:249-255.
6. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis: observations in 40 patients. Brain. 1989;112(pt 3):727-747.
7. Sayers ME, Chou SM, Calabrese LH. Inclusion body myositis: analysis of 32 cases. J Rheumatol. 1992;19:1385-1389.
8. Lindberg C, Persson LI, Björkander J, Oldfors A. Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases. Acta Neurol Scand. 1994;89:123-131.
9. Lynn SJ, Sawyers SM, Moller PW, O'Donnell JL, Chapman PT. Adult-onset inflammatory myopathy: North Canterbury experience 1989-2001. Intern Med J. 2005;35:170-173.
10. Rios G. Retrospective review of the clinical manifestations and outcomes in Puerto Ricans with idiopathic inflammatory myopathies. Clin Rheumatol. 2005;11:153-156.
11. Wintzen AR, Bots GT, de Bakker HM, Hulshof JH, Padberg GW. Dysphagia in inclusion body myositis. J Neurol Neurosurg Psychiatry. 1988;51:1542-1545.
12. Riminton DS, Chambers ST, Parkin PJ, Pollock M, Donaldson IM. Inclusion body myositis presenting solely as dysphagia. Neurology. 1993;43:1241-1243.
13. Williams RB, Grehan MJ, Hersch M, Andree J, Cook IJ. Biomechanics, diagnosis, and treatment outcome in inflammatory myopathy presenting as oropharyngeal dysphagia. Gut. 2003;52:471-478.
14. Peng A, Koffman BM, Malley JD, Dalakas MC. Disease progression in sporadic inclusion body myositis: observations in 78 patients. Neurology. 2000;55:296-298.
15. Miller RM, Langmore SE. Treatment efficacy for adults with oropharyngeal dysphagia. Arch Phys Med Rehabil. 1994;75:1256-1262.
16. Logemann JA. Behavioral management for oropharyngeal dysphagia. Folia Phoniatr Logop. 1999;51:199-212.
17. Langmore SE, Miller RM. Behavioral treatment for adults with oropharyngeal dysphagia. Arch Phys Med Rehabil. 1994;75:1154-1160.
18. Liu LW, Tarnopolsky M, Armstrong D. Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis. Can J Gastroenterol. 2004;18:397-399.
19. Kagen LJ, Hochman RB, Strong EW. Cricopharyngeal obstruction in inflammatory myopathy (polymyositis/dermatomyositis): report of three cases and review of the literature. Arthritis Rheum. 1985;28:630-636.
20. Houser SM, Calabrese LH, Strome M. Dysphagia in patients with inclusion body myositis. Laryngoscope. 1998;108:1001-1005.
21. Darrow DH, Hoffman HT, Barnes GJ, Wiley CA. Management of dysphagia in inclusion body myositis. Arch Otolaryngol Head Neck Surg. 1992;118:313-317.
22. Shapiro J, Martin S, DeGirolami U, Goyal R. Inflammatory myopathy causing pharyngeal dysphagia; a new entity. Ann Otol Rhinol Laryngol. 1996;105:331-335.
23. Verma A, Bradley W, Adesina AM, Sofferman R, Pendlebury WW. Inclusion body myositis with cricopharyngeus muscle involvement and severe dysphagia. Muscle Nerve. 1991;14:470-473.
24. Kahrilas PJ, Logemann JA, Krugler C, Flanagan E. Volitional augmentation of upper esophageal sphincter opening during swallowing. Am J Physiol. 1991;260(3, pt 1):G450-G456.
25. Elmståhl S, Bülow M, Ekberg O, Petersson M, Tegner H. Treatment of dysphagia improves nutritional conditions in stroke patients. Dysphagia. Spring 1999;14:61-66.
26. Griggs RC, Askanas V, DiMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol. 1995;38:705-713.
27. Logemann JA. Evaluation and Treatment of Swallowing Disorders. 2nd ed. Austin, Tex: PRO-ED; 1998:221.
28. Sonies BC. Evaluation and treatment of speech and swallowing disorders associated with myopathies. Curr Opin Rheumatol. 1997;9:486-495.
29. Wilson FC, St. Sauver J, Reed A. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota [abstract]. Arthritis Rheum. 2005;52(suppl):S312. Abstract 780.
30. Leonard RJ, Kendall KA, Johnson R, McKenzie S. Swallowing in myotonic muscular dystrophy: a videofluoroscopic study. Arch Phys Med Rehabil. 2001;82:979-985.